Withings' Innovative BeamO Gets FDA Green Light

A comprehensive health gadget: ECG, thermometer, and stethoscope in one

The revolutionary BeamO, a multifunctional health device by Withings, has achieved FDA approval. Featuring built-in capabilities for conducting an electrocardiogram, measuring body temperature, and functioning as a stethoscope, this device promises to perform all these diagnostic tests in under a minute. BeamO has officially reached the consumer market with a price tag of $250.

Revealed during the CES 2024 event, BeamO is aimed at enhancing telehealth services. Teaming up with a dedicated app, the device can transmit its data directly to healthcare professionals. As part of its health service package, Withings is also introducing a Cardio Check-Up feature. This service allows medical experts to review BeamO data remotely, providing a detailed heart health evaluation to users within just 24 hours.

Withings, known for its unique contributions to the home health and smart technology markets, continues to push the envelope. Their product lineup includes innovations like a state-of-the-art smartwatch, an advanced digital scale, and a toilet-based urine analysis device.